Weybosset Research & Management’s CVS Health CVS Stock Holding History

Weybosset Research & Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,985	Closed	-$321K	–	58
2017 Q2	$321K	Hold	3,985	–	–	0.21%	48
2017 Q1	$313K	Sell	3,985 -1,365	-26%	-$109K	0.21%	45
2016 Q4	$422K	Hold	5,350	–	–	0.3%	38
2016 Q3	$476K	Sell	5,350 -300	-5%	-$28.3K	0.34%	32
2016 Q2	$541K	Hold	5,650	–	–	0.41%	32
2016 Q1	$586K	Hold	5,650	–	–	0.5%	30
2015 Q4	$552K	Sell	5,650 -750	-12%	-$73.5K	0.49%	31
2015 Q3	$617K	Hold	6,400	–	–	0.46%	31
2015 Q2	$671K	Hold	6,400	–	–	0.44%	31
2015 Q1	$661K	Hold	6,400	–	–	0.42%	31
2014 Q4	$616K	Hold	6,400	–	–	0.39%	35
2014 Q3	$509K	Hold	6,400	–	–	0.34%	34
2014 Q2	$482K	Hold	6,400	–	–	0.31%	34
2014 Q1	$479K	Sell	6,400 -150	-2%	-$10.6K	0.32%	34
2013 Q4	$469K	Hold	6,550	–	–	0.31%	36
2013 Q3	$372K	Hold	6,550	–	–	0.27%	35
2013 Q2	$375K	Buy	+6,550	New	+$379K	0.28%	34

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Weybosset Research & Management's CVS Position: Q3 2017 in Review

Weybosset Research & Management sold out of CVS Health (CVS) in Q3 2017, closing a stake of 3,985 shares — an estimated $321K sold.

Weybosset Research & Management first reported a position in CVS in Q2 2013 and held it in 17 quarters. The position peaked at $671K in Q2 2015. 1,531 funds tracked by Wall St. Rank hold CVS as of Q3 2017.

Weybosset Research & Management reported no remaining CVS Health position as of Q3 2017 after selling out during the quarter.
Weybosset Research & Management sold 3,985 CVS Health shares in Q3 2017, an estimated $321K.
Weybosset Research & Management first reported a position in CVS Health in Q2 2013 and held it in 17 quarters.
Weybosset Research & Management's CVS Health position peaked at $671K in Q2 2015.
1,531 funds tracked by Wall St. Rank held CVS Health as of Q3 2017.

Based on Weybosset Research & Management's 13F filing for Q3 2017, filed 23 Oct 2017.